Skip to content Home / Companies / PVLA PVL
PALVELLA THERAPEUTICS, INC. (PVLA) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest PVLA Insider Trades
About PALVELLA THERAPEUTICS, INC. (PVLA) Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.
Headquarters WAYNE, PA
Employees 29
Listed 2024
Exchange XNAS https://www.palvellatx.com SEC filings for PVLA on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 12 12,906 $1.77M Grant or award 7 24,000 Option exercise 14 27,812
PVLA Insider Transactions (Form 4) 88 45 Form 4 filings on record, the earliest from Oct 28, 2024, newest first. Filing history page 1 of 2.
Date Insider Transaction Security Shares Price Value Aug 19, 2026 KG Kathleen Goin - Officer Option exercise Common Stock 2,154
Recent PVLA Form 8-K Filings 5
Recent PVLA Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 19, 2026 Goin Kathleen Officer 4,302 $647K View on EDGAR Jul 15, 2026 - -
PVLA Insider Trading - FAQ
What is the latest insider trade for PVLA? PALVELLA THERAPEUTICS, INC. (PVLA) had 11 insider filings in the last 90 days, with the most recent on 2026-08-20. The full record for PVLA runs to 45 Form 4 filings, the earliest from 2024-10-28. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying PVLA stock? No insider purchases of PVLA were filed in the last 90 days. 7 purchases are on record for this company.
How many insiders are selling PVLA stock? 12 insider sales of PVLA were filed in the last 90 days, totaling $1.77M.
Where can I see PVLA SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks PVLA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow PVLA insider buys? Create a free InsiderAlpha account and press Watch on this page to add PVLA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track PVLA insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free Aug 19, 2026
Market cap $2.16B
P/E ratio -
Dividend yield -
Average volume 252.7K
52 week high $161.38
52 week low $49.81
Today's high $153.28
Today's low $148.35
Open $148.65
Volume 191.8K
Previous close $150.33
Shares outstanding 14.41M Market cap
$2.16B
29 employees
PVLA Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 12 sales totaling $1.77M.
Most-Active PVLA Insiders - Last 90 Days 10 Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Aug 19, 2026 KG Kathleen Goin - Officer Option exercise Common Stock 2,148 $9.08 $20K
Aug 19, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 1,500 $151.39 $227K
Aug 19, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 1,998 $151.80 $303K
Aug 19, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 400 $153.00 $61K
Aug 19, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 102 $155.59 $16K
Aug 19, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 302 $156.77 $47K
Aug 19, 2026 KG Kathleen Goin - Officer Option exercise Stock Option (Right to Buy) 2,154 $0.00 -
Aug 19, 2026 KG Kathleen Goin - Officer Option exercise Stock Option (Right to Buy) 2,148 $0.00 -
Jul 15, 2026 KG Kathleen Goin - Officer Option exercise Common Stock 2,154 $7.14 $15K
Jul 15, 2026 KG Kathleen Goin - Officer Option exercise Common Stock 2,148 $9.08 $20K
Jul 15, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 522 $147.14 $77K
Jul 15, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 840 $148.40 $125K
Jul 15, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 1,029 $149.27 $154K
Jul 15, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 1,911 $150.25 $287K
Jul 15, 2026 KG Kathleen Goin - Officer Option exercise Stock Option (Right to Buy) 2,154 $0.00 -
Jul 15, 2026 KG Kathleen Goin - Officer Option exercise Stock Option (Right to Buy) 2,148 $0.00 -
Jun 29, 2026 MP Matthew Pauls - Director Grant or award Stock Option (Right to Buy) 6,000 $0.00 -
Jun 17, 2026 KG Kathleen Goin - Officer Option exercise Common Stock 2,154 $7.14 $15K
Jun 17, 2026 KG Kathleen Goin - Officer Option exercise Common Stock 2,148 $9.08 $20K
Jun 17, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 2,390 $110.26 $264K
Jun 17, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 1,887 $111.31 $210K
Jun 17, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 25 $112.23 $3K
Jun 17, 2026 KG Kathleen Goin - Officer Option exercise Stock Option (Right to Buy) 2,154 $0.00 -
Jun 17, 2026 KG Kathleen Goin - Officer Option exercise Stock Option (Right to Buy) 2,148 $0.00 -
Jun 10, 2026 GJ George M. Jenkins - Director Grant or award Stock Option (Right to Buy) 3,000 $0.00 -
Jun 10, 2026 EH Elaine J. Heron - Director Grant or award Stock Option (Right to Buy) 3,000 $0.00 -
Jun 10, 2026 JD John Doux - Director Grant or award Stock Option (Right to Buy) 3,000 $0.00 -
Jun 10, 2026 TD Todd C. Davis - Director Grant or award Stock Option (Right to Buy) 3,000 $0.00 -
Jun 10, 2026 TW Tadd S. Wessel - Director Grant or award Stock Option (Right to Buy) 3,000 $0.00 -
May 20, 2026 KG Kathleen Goin - Officer Option exercise Common Stock 2,154 $7.14 $15K
May 20, 2026 KG Kathleen Goin - Officer Option exercise Common Stock 2,148 $9.08 $20K
May 20, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 3,363 $110.35 $371K
May 20, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 891 $111.30 $99K
May 20, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 48 $111.90 $5K
May 20, 2026 KG Kathleen Goin - Officer Option exercise Stock Option (Right to Buy) 2,148 $0.00 -
May 20, 2026 KG Kathleen Goin - Officer Option exercise Stock Option (Right to Buy) 2,154 $0.00 -
Apr 15, 2026 KG Kathleen Goin - Officer Option exercise Common Stock 2,154 $7.14 $15K
Apr 15, 2026 KG Kathleen Goin - Officer Option exercise Common Stock 2,148 $9.08 $20K
Apr 15, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 1,502 $125.96 $189K
Apr 15, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 1,500 $127.13 $191K
Apr 15, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 561 $128.23 $72K
Apr 15, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 639 $129.17 $83K
Apr 15, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 100 $130.33 $13K
Apr 15, 2026 KG Kathleen Goin - Officer Option exercise Stock Option (Right to Buy) 2,154 $0.00 -
Apr 15, 2026 KG Kathleen Goin - Officer Option exercise Stock Option (Right to Buy) 2,148 $0.00 -
Apr 13, 2026 JD John Doux - Director Grant or award Stock Option (Right to Buy) 6,000 $0.00 -
Mar 30, 2026 GJ George M. Jenkins - Director Open-market purchase Common Stock 445 $112.30 $50K
Mar 18, 2026 KG Kathleen Goin - Officer Option exercise Common Stock 2,154 $7.14 $15K
Mar 18, 2026 KG Kathleen Goin - Officer Option exercise Common Stock 2,148 $9.08 $20K
Mar 18, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 2,268 $117.56 $267K
Mar 18, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 1,730 $118.37 $205K
Mar 18, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 304 $119.08 $36K
Mar 18, 2026 KG Kathleen Goin - Officer Option exercise Stock Option (Right to Buy) 2,154 $0.00 -
Mar 18, 2026 KG Kathleen Goin - Officer Option exercise Stock Option (Right to Buy) 2,148 $0.00 -
Feb 27, 2026 GJ George M. Jenkins - Director Open-market purchase Common Stock 4,000 $125.00 $500K
Feb 27, 2026 EH Elaine J. Heron - Director Open-market purchase Common Stock 2,400 $125.00 $300K
Feb 18, 2026 KG Kathleen Goin - Officer Option exercise Common Stock 2,148 $9.08 $20K
Feb 18, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 3,026 $79.16 $240K
Feb 18, 2026 KG Kathleen Goin - Officer Option exercise Common Stock 2,154 $7.14 $15K
Feb 18, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 1,276 $79.97 $102K
Feb 18, 2026 KG Kathleen Goin - Officer Option exercise Stock Option (Right to Buy) 2,154 $0.00 -
Feb 18, 2026 KG Kathleen Goin - Officer Option exercise Stock Option (Right to Buy) 2,148 $0.00 -
Feb 5, 2026 JM Jeffrey S. Martini - Officer Grant or award Stock Option (Right to Buy) 64,318 $0.00 -
Feb 5, 2026 WK Wes Kaupinen - Officer Grant or award Stock Option (Right to Buy) 124,603 $0.00 -
Feb 5, 2026 KG Kathleen Goin - Officer Grant or award Stock Option (Right to Buy) 48,956 $0.00 -
Jan 21, 2026 KG Kathleen Goin - Officer Option exercise Common Stock 2,154 $7.14 $15K
Jan 21, 2026 KG Kathleen Goin - Officer Option exercise Common Stock 2,148 $9.08 $20K
Jan 21, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 553 $95.49 $53K
Jan 21, 2026 KG Kathleen Goin - Officer Open-market sale Common Stock 3,749 $97.94 $367K
Jan 21, 2026 KG Kathleen Goin - Officer Option exercise Stock Option (Right to Buy) 2,154 $0.00 -
Jan 21, 2026 KG Kathleen Goin - Officer Option exercise Stock Option (Right to Buy) 2,148 $0.00 -
Nov 19, 2025 KG Kathleen Goin - Officer Option exercise Common Stock 2,148 $9.08 $20K
Nov 19, 2025 KG Kathleen Goin - Officer Open-market sale Common Stock 1,500 $85.72 $129K
Nov 19, 2025 KG Kathleen Goin - Officer Open-market sale Common Stock 2,802 $86.51 $242K
Nov 19, 2025 KG Kathleen Goin - Officer Option exercise Stock Option (Right to Buy) 2,154 $0.00 -
Nov 19, 2025 KG Kathleen Goin - Officer Option exercise Stock Option (Right to Buy) 2,148 $0.00 -
Nov 19, 2025 KG Kathleen Goin - Officer Option exercise Common Stock 2,154 $7.14 $15K
Jun 10, 2025 EH Elaine J. Heron - Director Grant or award Non-Qualified Stock Option (right to buy) 12,350 $0.00 -
Jun 10, 2025 CK Christopher P. Kiritsy - Director Grant or award Non-Qualified Stock Option (right to buy) 12,350 $0.00 -
Jun 10, 2025 GJ George M. Jenkins - Director Grant or award Non-Qualified Stock Option (right to buy) 12,350 $0.00 -
Apr 9, 2025 GJ George M. Jenkins - Director Open-market purchase Common Stock 2,500 $20.13 $50K
Apr 9, 2025 GJ George M. Jenkins - Director Open-market purchase Common Stock 2,490 $20.27 $50K
$IONS
IONIS PHARMACEUTICALS INC
